GLAXOSMITHKLINE IHC LIMITED - Profile & Financials

Accounts Submitted 28 May 2025

Confirmation Statement Submitted 29 Sept 2025

Net assets £240.48M £7.01M 2024 year on year

Total assets £28875.57M £5763.98M 2024 year on year

Total Liabilities £28635.09M £5756.97M 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover GLAXOSMITHKLINE IHC LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£730.15M

Increased by £584.12M (+400%)

Net Assets

£240.48M

Increased by £7.01M (+3%)

Total Liabilities

£28635.09M

Increased by £5756.97M (+25%)

Turnover

N/A

Employees

N/A

Debt Ratio

99%

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

5 active 9 resigned

Show resigned officers

						Status
Adam Walker	Director	British	United Kingdom	58	17 Jun 2015	Active
Alistair Robert Davidson	Director	British	England	53	17 Sept 2020	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-secretary	United Kingdom	Unknown	—	18 May 2010	Active
Timothy John Woodthorpe	Director	British	United Kingdom	47	6 Dec 2023	Active
Victoria Anne Whyte	Secretary	Unknown	Unknown	—	18 May 2010	Active

Shareholders

Shareholders (1)


Glaxosmithkline Finance Plc	100.0%	30,000,100	Ordinary	6 Jun 2016

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Glaxosmithkline Finance Plc

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

GLAXOSMITHKLINE IHC LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
29 Sept 2025	Confirmation Statement	Confirmation statement made on 2025-09-29 with no updates	View(3 pages)
28 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(23 pages)
7 Nov 2024	Confirmation Statement	Confirmation statement made on 2024-10-25 with no updates	View(3 pages)
23 Sept 2024	Officers	Change Person Secretary Company With Change Date	View(1 page)
17 Sept 2024	Officers	Change to director Mr Adam Walker on 2024-09-11	View(2 pages)